Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Route 92 Medical Announces $50 Million Series F Extension Equity Financing with Novo Holdings
Sep 23, 2024
Contract Type
partnership
San MateoManufacturingBiotechnologyHealthcareFinancial ServicesHealth CareMedical
Description
Route 92 Medical, Inc. announced a $50 million extension to its oversubscribed Series F financing, with Novo Holdings joining U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group in supporting the round. The funds will support global commercial expansion and pursuit of regulatory authorizations in new geographies for its neurovascular intervention portfolio.
Company Information
Company
Route 92 Medical
Location
San Mateo, California, United States
About
The Route 92 Medical platform utilizes the Monopoint operating system including an 088 catheter delivered to the neurovasculature using the specialized Tenzing catheter. The firm focuses on a diversified portfolio of lead investment positions and collaborates closely with each management team. The firm invests in early to late-stage businesses across a wide range of sectors with a focus on consumer, enterprise, and healthcare.